Forteo Injection: What Patients Need to Know

Forteo injection is a prescription medicine containing teriparatide, a bone-building treatment used for selected people with osteoporosis who have a high risk of fracture. It is given as a daily injection under the skin and is usually part of a broader plan that includes nutrition, exercise, fall prevention and follow-up care.

What Is Forteo Injection?

Forteo injection is a prescription medicine that contains teriparatide, a laboratory-made form of a naturally occurring parathyroid hormone fragment. Unlike many osteoporosis medicines that primarily slow bone breakdown, teriparatide helps stimulate the cells that build bone. For this reason, it is often described as an anabolic, or bone-building, osteoporosis treatment.

It is not the right treatment for every person with low bone density. Doctors may consider Forteo for postmenopausal women and men with osteoporosis at high risk of fractures, as well as for some adults with osteoporosis related to long-term glucocorticoid treatment. A high fracture risk may relate to previous fragility fractures, very low bone density, or other clinical factors assessed by the treating clinician.

Forteo is supplied in a prefilled injection pen in many settings and is administered into the fatty tissue just under the skin, commonly in the thigh or abdomen. A healthcare professional should teach the patient or caregiver how to use, store and dispose of the pen safely before treatment begins.

Why a Doctor May Recommend Teriparatide

Osteoporosis makes bones weaker and more likely to break, often without noticeable symptoms until a fracture occurs. Hip, spine and wrist fractures are common osteoporotic fractures, and spinal fractures can sometimes cause height loss, back pain or a rounded posture. Teriparatide may reduce the risk of certain fractures in appropriately selected patients by improving bone strength over time.

A clinician will look beyond a bone density scan alone when deciding whether Forteo may be helpful. They may review fracture history, age, menopausal status, family history, use of steroid medicines, falls, smoking, alcohol intake, nutritional status and medical conditions that may affect bone health. Evaluation and care for the underlying condition are important parts of osteoporosis management where such support is available.

Teriparatide is generally reserved for people who need a bone-building approach rather than being used as the first choice for everyone with osteopenia or osteoporosis. The choice between treatment options should be individualized, taking account of expected benefit, safety considerations, other medicines, practical preferences and access to follow-up.

How Forteo Injection Is Used

Forteo is taken as a daily subcutaneous injection, exactly as prescribed. The dose, treatment duration and technique should be determined by the treating clinician and confirmed in the local product information. Patients should not change the schedule, take extra doses after a missed injection, or stop treatment without discussing this with their healthcare team.

Before the first use, patients should receive practical instruction on using the injection pen, selecting injection sites and rotating sites as advised. The pen needle is used once and should be placed immediately into an appropriate sharps container. It should never be shared, even if the needle has been changed, because sharing injection devices can transmit infections.

Forteo pens generally need refrigerated storage and should be protected from freezing, excessive heat and light. Product-specific handling instructions can vary by country and device, so patients should check their package leaflet and ask a pharmacist about storage, travel and the date by which an opened pen must be discarded.

Expected Benefits and Follow-Up During Treatment

Bone responds gradually to treatment. A patient may not feel a change day to day, but treatment can improve bone mineral density and lower fracture risk in eligible people. The greatest benefit comes from taking the medicine consistently while also addressing factors that contribute to bone loss and falls.

Follow-up appointments allow the clinician to review injection technique, side effects, new fractures, nutrition and other medicines. Blood tests may be used when clinically appropriate to assess calcium levels, kidney function, vitamin D status or other potential causes of fragile bones. Bone density testing is usually repeated at intervals chosen by the clinician rather than immediately after treatment starts.

Teriparatide treatment is time-limited. After the prescribed course is completed, the clinician commonly recommends another osteoporosis medicine to help preserve gains in bone density. This transition is important and should be planned before the final pen is used, rather than leaving a gap in ongoing bone protection.

Side Effects, Precautions and Who May Not Be Suitable

Many people tolerate Forteo well, but side effects can occur. Possible effects include nausea, headache, dizziness, leg cramps, joint discomfort and injection-site reactions. Some people may feel light-headed, particularly after early doses, so it can be sensible to administer the injection where they can sit or lie down if needed.

Teriparatide can raise blood calcium levels, usually mildly and temporarily. The prescriber should know about a history of high calcium, kidney stones, kidney disease, hyperparathyroidism or use of calcium and vitamin supplements. Patients should not add or substantially increase supplements without medical advice, since individual calcium and vitamin D needs vary.

Forteo is not generally used in people with certain conditions associated with a higher baseline risk of bone cancer, including some bone diseases, bone metastases or skeletal malignancies, or previous radiation therapy involving the skeleton. It may also be unsuitable during pregnancy or breastfeeding. A full medical history, including previous cancer treatment and all prescription, over-the-counter and herbal products, helps the clinician assess safety.

• Tell the clinician about persistent nausea, unusual thirst, constipation, weakness or confusion, which may warrant assessment for high calcium.
• Report repeated dizziness, fainting, palpitations or symptoms that interfere with daily activities.
• Seek urgent care for signs of a serious allergic reaction, such as swelling of the face or throat, breathing difficulty, or widespread hives.

Supporting Bone Health Alongside Treatment

Forteo works best as one part of a comprehensive bone-health plan. Adequate dietary calcium and vitamin D are important, but the appropriate amount depends on diet, blood results, kidney health and other factors. A clinician or dietitian can help patients meet nutritional needs without taking unnecessary supplements.

Weight-bearing and muscle-strengthening exercise can support bone and balance when performed safely. Walking, stair climbing, resistance exercises and tailored balance training may be useful for many people, while individuals with vertebral fractures, severe osteoporosis or significant pain may need personalized advice from a physiotherapist before starting or changing an exercise programme.

Fall prevention is equally important. Helpful steps may include reviewing medications that cause drowsiness or dizziness, having vision checked, using stable footwear, improving home lighting, removing loose rugs and installing supports where needed. Avoiding smoking and limiting alcohol can also support overall bone health.

When to Seek Medical Care

Patients should contact their prescribing clinician promptly if they develop troublesome side effects, have difficulty using the injection pen, miss doses frequently, or are unsure about storage. They should also report a new fall, new bone pain, loss of height, sudden severe back pain or a suspected fracture, even if the injury seemed minor.

Urgent medical assessment is needed for symptoms of a severe allergic reaction, such as trouble breathing, facial or throat swelling, or fainting. Severe or persistent dizziness, chest symptoms, confusion, or symptoms that could suggest significant calcium imbalance should also be assessed without delay.

Regular review helps ensure that treatment remains appropriate as health needs change. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can assess and treat osteoporosis for international patients, including treatment planning and follow-up. Decisions about Forteo should always be made with a qualified doctor who knows the patient’s medical history.

Frequently asked questions

Is Forteo injection the same as teriparatide?

Forteo is a brand name for teriparatide. Teriparatide is the active medicine that stimulates new bone formation and may also be available under other brand names or as other approved products, depending on the country.

Who usually needs Forteo injection?

Forteo may be considered for adults with osteoporosis who have a high or very high risk of fracture. This can include people with previous fragility fractures, very low bone density, or osteoporosis associated with long-term glucocorticoid use, but eligibility is assessed individually.

How quickly does Forteo start working?

Forteo begins affecting bone remodeling after treatment starts, but meaningful changes in bone density and fracture risk occur over time. Patients usually do not feel the medicine working, so regular use and planned follow-up are important.

Can Forteo be used with calcium and vitamin D?

Many patients need adequate calcium and vitamin D intake while receiving osteoporosis treatment. However, supplements should be reviewed by the prescriber because teriparatide can increase calcium levels and individual requirements differ.

What happens after Forteo treatment ends?

A clinician will usually recommend a follow-on osteoporosis medicine after teriparatide treatment is completed. This helps maintain the improvement in bone density achieved during the bone-building treatment.

Can Forteo injection cause dizziness?

Dizziness or light-headedness can occur, particularly with early doses. Patients should administer the injection in a setting where they can sit or lie down if necessary, and should contact their clinician if dizziness is severe, recurrent or associated with fainting.

References

• U.S. Food and Drug Administration
• National Osteoporosis Foundation
• International Osteoporosis Foundation
• National Institute of Arthritis and Musculoskeletal and Skin Diseases
• Mayo Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.